Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TCF4 | P15884 | 1/20 | 0.59 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 19/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10291465 | 0.94 | TCF4 (0.59) | TCF4CTNNB1CYP3A4 | |
| SCHEMBL16510506 | 0.93 | CYP3A4 (0.57) | TCF4CTNNB1CYP3A4 | |
| SCHEMBL2890703 | 0.93 | CYP3A4 (0.66) | CYP3A4 | |
| SCHEMBL2875935 | 0.93 | CYP3A4 (0.66) | CYP3A4 | |
| SCHEMBL10291470 | 0.93 | CYP3A4 (0.66) | CYP3A4 | |
| SCHEMBL763324 | 0.90 | CYP3A4 (0.63) | CYP3A4 | |
| SCHEMBL763545 | 0.89 | CYP3A4 (0.63) | CYP3A4 | |
| SCHEMBL12173443 | 0.87 | TCF4 (0.56) | TCF4CTNNB1CYP3A4 | |
| SCHEMBL762652 | 0.87 | TCF4 (0.53) | TCF4CTNNB1CYP3A4 | |
| SCHEMBL2899810 | 0.87 | CYP3A4 (0.68) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138337-B2 | Reverse-turn mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2012-03-20 | — | — | US | disclosed |
| US-20100240662-A1 | REVERSE-TURN MIMETICS AND METHOD RELATING THERETO | CHOONGWAE PHARMA CORPORATION (KR) | 2010-09-23 | — | — | US | disclosed |
| US-20100240662-A1 | REVERSE-TURN MIMETICS AND METHOD RELATING THERETO | CHOONGWAE PHARMA CORPORATION (KR) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240662-A1 | REVERSE-TURN MIMETICS AND METHOD RELATING THERETO | WNT1, WNT3, APC | TCF4 60/4885CTNNB1 9/4885CYP3A4 3595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.